Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats
Previous investigations have shown that D. viscosa herbal extract is often used to treat a variety of diseases. Therefore, the purpose of this study was to investigate any additional potential impacts on rat liver and kidney damage induced by diabetes. Streptozotocin (STZ) (60 mg/kg/day) was given a...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016423001548 |
_version_ | 1797754024708014080 |
---|---|
author | Ahmed Z. Alanazi Salim S. Al-Rejaie Mohammed M. Ahmed Khalid Alhazzani Khaled Alhosaini Homood M. As Sobeai Sary Alsanea Perwez Alam Omer M. Almarfadi Ali S. Alqahtani Abdullah S. Alhamed Mohammed Alqinyah Hussain N. Alhamami Mohammed F. Almutery Mohamed Mohany |
author_facet | Ahmed Z. Alanazi Salim S. Al-Rejaie Mohammed M. Ahmed Khalid Alhazzani Khaled Alhosaini Homood M. As Sobeai Sary Alsanea Perwez Alam Omer M. Almarfadi Ali S. Alqahtani Abdullah S. Alhamed Mohammed Alqinyah Hussain N. Alhamami Mohammed F. Almutery Mohamed Mohany |
author_sort | Ahmed Z. Alanazi |
collection | DOAJ |
description | Previous investigations have shown that D. viscosa herbal extract is often used to treat a variety of diseases. Therefore, the purpose of this study was to investigate any additional potential impacts on rat liver and kidney damage induced by diabetes. Streptozotocin (STZ) (60 mg/kg/day) was given as a single dosage to cause type 1 diabetes. After then, diabetic rats received oral doses of D. viscosa for four weeks at 150 and 300 mg/kg/day. Blood, liver, and kidney tissues were collected at the end of the treatment and examined. Analysis was made of the serum lipid profile, liver, and kidney functions, as well as blood biochemistry. Moreover, the levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), prostaglandin E-2 (PGE-2), and nitric oxide (NO) were estimated in serum. In liver and kidney samples, thiobarbituric acid reactive substances (TBARs) and reduced glutathione (GSH), as well as the pro-inflammatory cytokines and enzymatic activities of glutathione peroxidase (GPx), glutathione reeducates (GR), glutathione-S-transferase (GST), catalase (CAT), and superoxide dismutase (SOD) were analyzed. Histological changes in liver and kidney cross-sections were also observed. Our findings demonstrated that D. viscosa dramatically decreased pro-inflammatory indicators in blood, kidney, and liver tissues as well as blood glucose, and restored insulin levels, and lipid profiles. Additionally, it significantly raises the antioxidant enzyme activity SOD, CAT, GPx, and GST, while significantly lowering TBARs levels. The above-mentioned biochemical changes that took place in tissues were further supported by histological alterations. These findings imply that D. viscosa protects against STZ-induced hyperglycemia, aberrant lipid synthesis, and oxidative stress and that these benefits may be mediated by interacting with various targets to increase the levels of antioxidant enzymes in the liver and kidneys. Its mode of action and safety for use as medicine against various metabolic problems caused by diabetes require more research. |
first_indexed | 2024-03-12T17:27:27Z |
format | Article |
id | doaj.art-602507ebe5c640fbb50a64087a4c681e |
institution | Directory Open Access Journal |
issn | 1319-0164 |
language | English |
last_indexed | 2024-03-12T17:27:27Z |
publishDate | 2023-08-01 |
publisher | Elsevier |
record_format | Article |
series | Saudi Pharmaceutical Journal |
spelling | doaj.art-602507ebe5c640fbb50a64087a4c681e2023-08-05T05:15:13ZengElsevierSaudi Pharmaceutical Journal1319-01642023-08-01318101669Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in ratsAhmed Z. Alanazi0Salim S. Al-Rejaie1Mohammed M. Ahmed2Khalid Alhazzani3Khaled Alhosaini4Homood M. As Sobeai5Sary Alsanea6Perwez Alam7Omer M. Almarfadi8Ali S. Alqahtani9Abdullah S. Alhamed10Mohammed Alqinyah11Hussain N. Alhamami12Mohammed F. Almutery13Mohamed Mohany14Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi Arabia; Corresponding author at: Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Building 23 (College of Dentistry), 1st floor, Office 1A 31, P.O. Box 2457, Riyadh 11451, Saudi Arabia.Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaDepartment of Pathology and Laboratory Medicine, College of Medicine, King Saud, University Medical City, King Saud University, Riyadh, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh 1145, Saudi ArabiaPrevious investigations have shown that D. viscosa herbal extract is often used to treat a variety of diseases. Therefore, the purpose of this study was to investigate any additional potential impacts on rat liver and kidney damage induced by diabetes. Streptozotocin (STZ) (60 mg/kg/day) was given as a single dosage to cause type 1 diabetes. After then, diabetic rats received oral doses of D. viscosa for four weeks at 150 and 300 mg/kg/day. Blood, liver, and kidney tissues were collected at the end of the treatment and examined. Analysis was made of the serum lipid profile, liver, and kidney functions, as well as blood biochemistry. Moreover, the levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), prostaglandin E-2 (PGE-2), and nitric oxide (NO) were estimated in serum. In liver and kidney samples, thiobarbituric acid reactive substances (TBARs) and reduced glutathione (GSH), as well as the pro-inflammatory cytokines and enzymatic activities of glutathione peroxidase (GPx), glutathione reeducates (GR), glutathione-S-transferase (GST), catalase (CAT), and superoxide dismutase (SOD) were analyzed. Histological changes in liver and kidney cross-sections were also observed. Our findings demonstrated that D. viscosa dramatically decreased pro-inflammatory indicators in blood, kidney, and liver tissues as well as blood glucose, and restored insulin levels, and lipid profiles. Additionally, it significantly raises the antioxidant enzyme activity SOD, CAT, GPx, and GST, while significantly lowering TBARs levels. The above-mentioned biochemical changes that took place in tissues were further supported by histological alterations. These findings imply that D. viscosa protects against STZ-induced hyperglycemia, aberrant lipid synthesis, and oxidative stress and that these benefits may be mediated by interacting with various targets to increase the levels of antioxidant enzymes in the liver and kidneys. Its mode of action and safety for use as medicine against various metabolic problems caused by diabetes require more research.http://www.sciencedirect.com/science/article/pii/S1319016423001548Dodonaea viscosaDiabetesStreptozotocinOxidative stressInflammation |
spellingShingle | Ahmed Z. Alanazi Salim S. Al-Rejaie Mohammed M. Ahmed Khalid Alhazzani Khaled Alhosaini Homood M. As Sobeai Sary Alsanea Perwez Alam Omer M. Almarfadi Ali S. Alqahtani Abdullah S. Alhamed Mohammed Alqinyah Hussain N. Alhamami Mohammed F. Almutery Mohamed Mohany Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats Saudi Pharmaceutical Journal Dodonaea viscosa Diabetes Streptozotocin Oxidative stress Inflammation |
title | Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats |
title_full | Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats |
title_fullStr | Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats |
title_full_unstemmed | Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats |
title_short | Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats |
title_sort | protective role of dodonaea viscosa extract against streptozotocin induced hepatotoxicity and nephrotoxicity in rats |
topic | Dodonaea viscosa Diabetes Streptozotocin Oxidative stress Inflammation |
url | http://www.sciencedirect.com/science/article/pii/S1319016423001548 |
work_keys_str_mv | AT ahmedzalanazi protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT salimsalrejaie protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT mohammedmahmed protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT khalidalhazzani protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT khaledalhosaini protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT homoodmassobeai protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT saryalsanea protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT perwezalam protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT omermalmarfadi protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT alisalqahtani protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT abdullahsalhamed protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT mohammedalqinyah protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT hussainnalhamami protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT mohammedfalmutery protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats AT mohamedmohany protectiveroleofdodonaeaviscosaextractagainststreptozotocininducedhepatotoxicityandnephrotoxicityinrats |